Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
Public ClinicalTrials.gov record NCT05590585. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema, is a condition that causes the skin to become itchy, dry, and cracked. From the previous studies on the study drug, it is seen that the study drug has an acceptable safety and effectiveness in participants with atopic dermatitis. The aim of this study is to get additional information on the safety and effectiveness of the study drug, particularly the information on aspects of atopic dermatitis in skin of color participants. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in your blood at different times * How much the study drug improves quality of life and mental health
Study identification
- NCT ID
- NCT05590585
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 124 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 11, 2023 (Actual)
- Primary completion
- Nov 14, 2024 (Actual)
- Completion
- Nov 14, 2024 (Actual)
- Last update posted
- May 27, 2026
2023 – 2024
United States locations
- U.S. sites
- 30
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin & Beauty Dermatology Center | Birmingham | Alabama | 35203 | — |
| The University Of Alabama At Birmingham | Birmingham | Alabama | 35233 | — |
| C2 Research Center, LLC | Montgomery | Alabama | 36117 | — |
| Center for Dermatology Clinical Research, inc. | Fremont | California | 94538 | — |
| UCSD/ Rady Children's Hospital | San Diego | California | 92123 | — |
| UCSF | San Francisco | California | 94118 | — |
| SF Research Institute | San Francisco | California | 94127 | — |
| University of Miami Miller School of Medicine | Miami | Florida | 33136 | — |
| Skin and Cancer Associates, LLP | Miami | Florida | 33137 | — |
| Century Research LLC | Miami | Florida | 33173 | — |
| Advanced Medical Research PC | Atlanta | Georgia | 30328 | — |
| Atlanta Biomedical Clinical Research LLC | Atlanta | Georgia | 30331 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Callender Dermatology and Cosmetic Center | Glenn Dale | Maryland | 20769 | — |
| Dermatology and Skin Cancer Specialists, LLC dba US Dermatology Partners | Rockville | Maryland | 20850 | — |
| Wayne State University Physician Group Dermatology | Dearborn | Michigan | 48126 | — |
| Revival Research Institute , LLC | Troy | Michigan | 48084 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Rao Dermatology | Atlantic Highlands | New Jersey | 07716 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| NYC Health + Hospital , Elmhurst Hospital Center | Elmhurst | New York | 11373 | — |
| Markowitz Medical | New York | New York | 10128 | — |
| Philip Fried, MD PLLC | The Bronx | New York | 10463 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| National Allergy and Asthma Research, LLC. | North Charleston | South Carolina | 29420 | — |
| Center for Clinical Studies, LTD.LLP | Houston | Texas | 77004 | — |
| Heights Dermatology & Aesthetic Center - Heights Location | Houston | Texas | 77008 | — |
| RFSA Dermatology | San Antonio | Texas | 78213 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05590585, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05590585 live on ClinicalTrials.gov.